North Estonia Medical Centre
Tallinn, Harju, 13419, Estonia
NCT Number: NCT07490730
Adult patients diagnosed with common bile duct stones scheduled for laparoscopic cholecystectomy undergo intraoperative endoscopic sphincteric balloon dilatation (EBD). Postoperatively patients receive a MRT to confirm bile duct clearance. Patients are monitored for 30 day postoperative complications. EBD results are compared with those of ERCP that is more commonly used for bile duct clearance.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Tallinn, Harju, 13419, Estonia
Adult patients diagnosed with common bile duct stones scheduled for laparoscopic cholecystectomy undergo intraoperative endoscopic sphincteric balloon dilatation (EBD). Postoperatively patients receive a MRT to confirm bile duct clearance. Patients are monitored for 30 day postoperative complications. EBD results are compared with those of ERCP that is more commonly used for bile duct clearance.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 30 days
The clearance rate of common bile duct from stones confirmed by post-procedural Magnetic Resonance Cholangiopancreatography (MRCP)
Time frame: 30 days
The duration of the operation in minutes from incision to skin closure; post-operative complications that were registered within 30 days after the operation, patients' hospital length of stay in days
North Estonia Medical Centre
Other
Antegrade Transcystic Balloon Dilatation of the Papillary Sphincter During Emergency Laparoscopic Cholecystectomy for Common Bile Duct Stones: A Prospective Validation Study With Postoperative MRCP Confirmation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07595692
Biliary Tract Diseases, Cholelithiasis
Dhaka, Chattogram, Bangladesh
View Trial DetailsNCT07465406
Biliary Tract Diseases, Cholelithiasis
Karachi, Pakistan
View Trial DetailsNCT05975385
Biliary Tract Diseases, Cholecystitis
Houston, Texas, United States
View Trial DetailsNCT07388251
Biliary Tract Diseases, Cholelithiasis
Cairo, Cairo Governorate, Egypt
View Trial Details